Literature DB >> 12041669

Antithymocyte globulin in the treatment of D-penicillamine-induced aplastic anemia.

Haruki Kondo1, Kanae Narita.   

Abstract

A patient who received antithymocyte globulin therapy for aplastic anemia due to D-penicillamine therapy is described. Bone marrow recovery and peripheral blood recovery were complete 1 month and 3 months, respectively, after treatment, and blood transfusion or other therapies were not necessary in a follow-up period of more than 2 years. Use of antithymocyte globulin may be the optimal treatment of D-penicillamine-induced aplastic anemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12041669     DOI: 10.1007/bf02982129

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

Review 1.  The pathophysiology of acquired aplastic anemia.

Authors:  N S Young; J Maciejewski
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Antithymocyte globulin in the treatment of gold induced severe aplastic anemia.

Authors:  J M Alvaro-Gracia; S Castañeda-Sanz; R Arranz; A Ariza; P Sabando; C Ossorio
Journal:  J Rheumatol       Date:  1988-01       Impact factor: 4.666

3.  Letter: Marrow aplasia and penicillamine.

Authors: 
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

Review 4.  Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation.

Authors:  E Gluckman; A Marmont; B Speck; E C Gordon-Smith
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

5.  Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.

Authors:  A S Weiss; J A Markenson; M S Weiss; W H Kammerer
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

Review 6.  Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.

Authors:  B M Camitta; K Doney
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

7.  Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.

Authors:  B Fishel; M Tishler; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

8.  Apparent cure of rheumatoid arthritis by bone marrow transplantation.

Authors:  R M Lowenthal; M L Cohen; K Atkinson; J C Biggs
Journal:  J Rheumatol       Date:  1993-01       Impact factor: 4.666

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

10.  Multiple abnormalities in immunoregulatory function of synovial compartment T cells in patients with rheumatoid arthritis. Recognition of a helper augmentation effect.

Authors:  P L Romain; G R Burmester; R W Enlow; R J Winchester
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.